Combined genetic and epigenetic analysis of sporadic colon cancer suggest that it can no longer be viewed as a single disease. There are at least three different subsets with distinct clinico-pathologic features, with important implications for preventions, screening, and therapy.
No takes yet. Share an insight, caveat, or question.
Jean‐Pierre J. Issa (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: